Navigation Links
High Brightness Tetrapod Quantum Dots Developed

CARSON CITY, Nev., Nov. 13, 2012 /PRNewswire/ -- Millions of laboratory tests and biological assays are conducted every year to explore cellular processes. Quantum Materials Corporation has now developed tetrapod quantum dots, improved fluorescent markers that can more effectively gain knowledge of how body systems function and chronic conditions and diseases such as cancer metabolize and impact health and longevity.

Conventionally, fluorescent tags or tracers have been used to "light up" and distinguish one type of cell from another to gain these insights into biological functions.  However, these tags and other dyes have drawbacks to use, including quick fading and tedious procedures to differentiate more than one type of cell or bio-molecule at a time.

The discovery of quantum dots as a fluorescent marker has made these biochemical assays quicker and more robust for scientific discovery.  The quantum dots are proving to be more stable and have a unique capability to shine in multiple colors under a single light source excitation so that a single assay can produce much more information for researchers.

Quantum Materials Corporation has now increased the brightness of its tetrapod-shaped quantum dots for this application.  At a quantum yield greater than 80%, the dots are bright enough to be functionalized in a wide variety of ways to perform as novel probes into as-of-yet-not-fully-understood biological systems.  This functionalization typically will allow researchers to modify the base quantum dot so that a biological tag can be made with an appropriate protein or antibody for a very specific marking within the laboratory sample.

Quantum Materials' CEO Stephen Squires noted that, "We believe that the brightness of our Tetrapod Quantum Dots along with other unique features, will give key players in the pharmaceutical and biological industries a much awaited, high performance tool to dig in deeper to the mysteries of physiological conditions that have eluded efforts for cures."

In combination with Quantum Materials use of high throughput microreactor technology the production of the high quantum yield, bright quantum dots will potentially enable the millions of annual assays to expand significantly in number and provide desperately needed information to be quickly available to the world's leading researchers.

In addition to the performance increases for biomedical applications, Quantum Materials believes that the technology breakthrough will also enable its subsidiary, Solterra Renewable Materials to increase conversion efficiencies for its thin-film quantum dot solar cell.  With advances in the solar cell, QMC expects to then apply insight gained in the added performance to other quantum dot applications such as LED lighting and displays.

About Quantum Materials, Inc., Solterra Renewable Technologies, Inc.

QUANTUM MATERIALS CORPORATION has a steadfast vision that advanced technology is the solution to global issues related to cost, efficiency and increasing energy usage. Quantum dot semiconductors enable a new level of performance in a wide array of established consumer and industrial products, including low cost flexible solar cells, low power lighting and displays and biomedical research applications. Quantum Materials Corporation intends to invigorate these markets through cost reduction and moving laboratory discovery to commercialization with volume manufacturing methods to establish a growing line of innovative high performance products. (

SOLTERRA RENEWABLE TECHNOLOGIES, INC. is singularly positioned to lead the development of truly sustainable and cost-effective solar technology by introducing a new dimension of cost reduction by replacing silicon wafer-based solar cells with high-production, low-cost, efficient Quantum Dot-based solar cells. Solterra is a wholly-owned subsidiary of Quantum Materials, Inc. (

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at or from our website. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

For more information, please contact:
Art Lamstein (Director of Marketing) at:, 415-883-4556

SOURCE Quantum Materials Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Good news for nanomedicine: Quantum dots appear safe in pioneering study on primates
2. Test developed to detect early-stage diseases with naked eye
3. New cranial neural crest cell line developed
4. Humanized mice developed at OHSU enable malaria research breakthrough at Seattle BioMed
5. New long-term antimicrobial catheter developed
6. Electronic nose prototype developed
7. Composite nanofibers developed by Penn scientists next chapter in orthopaedic biomaterials
8. Grassroots approach to conservation developed
9. The first chemical circuit developed
10. Blossom end rot plummets in Purdue-developed transgenic tomato
11. Mini-CT scanner developed as a teaching tool
Post Your Comments:
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem Cells Group ... professionals from Central America and abroad for the first Iberoamerican Convention on Aesthetic ... 17-19, 2016. Testart will present and discuss new trends in anti-aging stem cell ...
(Date:11/30/2015)... radiology technique shows promise for helping morbidly obese patients lose ... presented today at the annual meeting of the Radiological Society ... --> --> Gastric artery embolization ... way to stop bleeding in emergency situations, but the idea ... is new. Mubin Syed , M.D., interventional radiologist ...
(Date:11/30/2015)... 30, 2015 Harvard Apparatus Regenerative Technology, ... company developing bioengineered organ implants for life-threatening conditions, ... The NASDAQ Stock Market that it has regained ... letter noted that as a result of the ... exceeded $1.00 per share for more than ten ...
(Date:11/30/2015)...  Champions Oncology, Inc. (CSBR), engaged in the development ... development and use of oncology drugs, today announced that ... presenting at the LD MICRO Investor Conference on Wednesday, ... The conference, held at the Luxe Sunset Bel Air ... will feature 200 small/micro-cap companies and is expected to ...
Breaking Biology Technology: